| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.22▲ | 10.28▲ | 10.26▲ | 9.96▲ | 10.40▼ |
| MA10 | 10.21▲ | 10.26▲ | 10.16▲ | 10.16▲ | 9.62▲ |
| MA20 | 10.23▲ | 10.18▲ | 10.16▲ | 10.52▼ | 8.82▲ |
| MA50 | 10.25▲ | 10.06▲ | 9.96▲ | 9.65▲ | 10.34▼ |
| MA100 | 10.17▲ | 10.00▲ | 10.32▼ | 8.71▲ | 12.35▼ |
| MA200 | 10.17▲ | 10.36▼ | 10.12▲ | 9.75▲ | 9.51▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.005▲ | 0.019▲ | -0.119▼ | 0.334▲ |
| RSI | 57.320▲ | 57.976▲ | 58.579▲ | 53.584▲ | 54.309▲ |
| STOCH | 60.281 | 71.145 | 81.802▲ | 25.547 | 65.350 |
| WILL %R | 0.000▲ | -21.739▲ | -19.608▲ | -51.205 | -32.864 |
| CCI | 171.705▲ | 43.941 | 88.363 | -22.135 | 66.273 |
|
Monday, August 11, 2025 07:32 PM
Immunome's varegacestat shows promising efficacy in desmoid tumors, with phase 3 topline data expected by 2025-end. Read why IMNM stock is a Buy.
|
|
Saturday, August 09, 2025 06:40 AM
Immunome, Inc. (NASDAQ:IMNM) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus estimated revenue numbers rose, with ...
|
|
Wednesday, August 06, 2025 02:32 PM
Key Points GAAP revenue surged to $4.0 million in Q2 2025, beating analyst expectations by 381.9%. GAAP net loss per share improved to $(0.50) in Q2 2025, slightly better than the estimated $(0.52).
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 9.95 | 10.38 | 9.92 | 10.28 | 674,787 |
| 14/08/25 | 9.81 | 10.21 | 9.81 | 9.94 | 576,802 |
| 13/08/25 | 10.02 | 10.38 | 9.98 | 10.01 | 983,058 |
| 12/08/25 | 9.69 | 9.98 | 9.47 | 9.91 | 524,971 |
| 11/08/25 | 9.60 | 9.83 | 9.4736 | 9.66 | 676,199 |
| 08/08/25 | 9.74 | 10.029 | 9.60 | 9.69 | 580,876 |
| 07/08/25 | 10.71 | 10.75 | 9.80 | 9.87 | 1,109,370 |
| 06/08/25 | 10.80 | 10.80 | 10.24 | 10.46 | 538,261 |
| 05/08/25 | 10.90 | 11.13 | 10.77 | 10.85 | 651,906 |
| 04/08/25 | 10.62 | 11.09 | 10.38 | 10.95 | 436,884 |
|
|
||||
|
|
||||
|
|